| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.34 | 7e-24 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.32 | 1e-18 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-16 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.29 | 8e-16 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.27 | 6e-15 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-14 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 5e-13 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-12 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-10 |